Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 501–600 of 1,014
Tracking Changes following Spinal Cord Injury: Insights from Neuroimaging
Freund, P., Curt, A. E. P., Friston, K. J., & Thompson, A. J. (2012) · The Neuroscientist · doi:10.1177/1073858412449192 · Cited by 96
Diversity of Reactive Astrogliosis in CNS Pathology: Heterogeneity or Plasticity?
Moulson, A. J., Squair, J. W., Franklin, R. J. M., Tetzlaff, W., & Assinck, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.703810 · Cited by 106
Didangelos, A., Puglia, M., Iberl, M., Sanchez-Bellot, C., Roschitzki, B., & Bradbury, E. J. (2016) · Scientific Reports · doi:10.1038/srep21607 · Cited by 96
Self-citationYokota, K., Kobayakawa, K., Saito, T., Hara, M., Kijima, K., Ohkawa, Y., Harada, A., Okazaki, K., Ishihara, K., Yoshida, S., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.11.010 · Cited by 97
“…chondroitin sulfate proteoglycans at the lesion site and promoted axonal regeneration, resulting in a better functional outcome after SCI. 59 However, for establishing a treatment O pen - f i e l d sc o r e for human SCI, chondroitinase ABC administration carries a risk of infection with…”
BackgroundMiracles and molecules—progress in spinal cord repair
Blight, A. R. (2002) · Nature Neuroscience · doi:10.1038/nn939 · Cited by 103
“Application of bacterial chondroitinase to the site of injury breaks down this barrier to axon growth and promotes substantial axonal growth and functional recovery in a rat model of cord injur”
BackgroundHuman xylosyltransferases in health and disease
Götting, C., Kuhn, J., & Kleesiek, K. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7069-z · Cited by 101
Bone Marrow–Derived Mesenchymal Stem Cell Transplantation for Chronic Spinal Cord Injury in Rats
Kim, J.-W., Ha, K.-Y., Molon, J. N., & Kim, Y.-H. (2013) · Spine · doi:10.1097/brs.0b013e31829839fa · Cited by 95
Glycan sulfation patterns define autophagy flux at axon tip via PTPRσ-cortactin axis
Sakamoto, K., Ozaki, T., Ko, Y., Tsai, C.-F., Gong, Y., Morozumi, M., Ishikawa, Y., Uchimura, K., Nadanaka, S., Kitagawa, H., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0274-x · Cited by 105
Zhao, R.-R., Muir, E. M., Alves, J. N., Rickman, H., Allan, A. Y., Kwok, J. C., Roet, K. C. D., Verhaagen, J., Schneider, B. L., Bensadoun, J.-C., et al. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.08.003 · Cited by 94
Self-citationLamprianou, S., Chatzopoulou, E., Thomas, J.-L., Bouyain, S., & Harroch, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108774108 · Cited by 92
Role of myelin-associated inhibitors in axonal repair after spinal cord injury
Lee, J. K., & Zheng, B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.001 · Cited by 95
Yi, J., Katagiri, Y., Susarla, B., Figge, D., Symes, A. J., & Geller, H. M. (2012) · Journal of Comparative Neurology · doi:10.1002/cne.23156 · Cited by 93
“…proteoglycans in the mouse cerebral cortex, we investigated their localization by double-labeling experiments using antibodies against the CSPGs aggrecan, neurocan, phosphacan, and versican along with the lectin WFA, which recognizes terminal GalNAc and is a marker for PNNs (Brauer et al., 1993).”
MethodStarkey, M. L., Bartus, K., Barritt, A. W., & Bradbury, E. J. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12017 · Cited by 108
“Saline was used as the control treatment in line with previous studies (Bradbury et al., 2002; Barritt et al., 2006; Houle et al., 2006; Cafferty et al., 2008; Tom et al., 2009b; Alilain et al., 2011) and because previous work has shown that treatment with saline or a control enzyme such as”
BackgroundMethodResultSelf-citationRecent advances in the therapeutic uses of chondroitinase ABC
Muir, E. M., de Winter, F., Verhaagen, J., & Fawcett, J. W. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113032 · Cited by 102
Self-citationInjury and repair in the neurovascular unit
Xing, C., Hayakawa, K., Lok, J., Arai, K., & Lo, E. H. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000019 · Cited by 92
Neuroprotective Effects of Sulforaphane after Contusive Spinal Cord Injury
Benedict, A. L., Mountney, A., Hurtado, A., Bryan, K. E., Schnaar, R. L., Dinkova-Kostova, A. T., & Talalay, P. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2474 · Cited by 91
Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC
Filous, A. R., Miller, J. H., Coulson‐Thomas, Y. M., Horn, K. P., Alilain, W. J., & Silver, J. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20820 · Cited by 89
“Studies have shown that the digestion of the inhibitory chondroitin sulfate chains with chondroitinase enhances neuronal regeneration (Krekoski et al., 2001; Moon et al., 2001; Bradbury et al., 2002; Fouad et al., 2005; Steinmetz et al., 2005; Houle et al., 2006; Pizzorusso et al., 2006; Cafferty et al., 2008; Tester…”
BackgroundFleisch, V. C., Fraser, B., & Allison, W. T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.012 · Cited by 99
Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury
Alizadeh, A., & Karimi‐Abdolrezaee, S. (2016) · The Journal of Physiology · doi:10.1113/jp270895 · Cited by 102
“CSPGs were first identified for their potent inhibitory influence on axonal regeneration and plasticity in the injured spinal cord (Silver, 1994; Bradbury et al. 2002).”
BackgroundSialidase enhances spinal axon outgrowth in vivo
Yang, L. J. S., Lorenzini, I., Vajn, K., Mountney, A., Schramm, L. P., & Schnaar, R. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604613103 · Cited by 89
Hyatt, A. J. T., Wang, D., Kwok, J. C. F., Fawcett, J. W., & Martin, K. R. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.026 · Cited by 92
Self-citationCheah, M., Andrews, M. R., Chew, D. J., Moloney, E. B., Verhaagen, J., Fässler, R., & Fawcett, J. W. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0901-16.2016 · Cited by 94
“The upregulated CSPGs in the glial scar have an inhibitory effect on axon growth, and treatments directly targeting CSPGs, such as chondroitinase, can permit some axon regeneration (Friedlander et al., 1994; Moon et al., 2001; Bradbury et al., 2002; Cafferty et al., 2007).”
BackgroundSelf-citationForostyak, S., Homola, A., Turnovcova, K., Svitil, P., Jendelova, P., & Sykova, E. (2014) · Stem Cells · doi:10.1002/stem.1812 · Cited by 92
McKillop, W. M., Dragan, M., Schedl, A., & Brown, A. (2013) · Glia · doi:10.1002/glia.22424 · Cited by 86
“Serotonergic projections synapsing in the dorsal horn modulate pain sensation (Bardin et al., 2000; Calejesan et al., 1998), serotonergic projections targeting sympathetic preganglionic neurons in the intermediolateral cell column (IML) contribute to autonomic regulation (Allen and Cechetto, 1994),…”
BackgroundTauchi, R., Imagama, S., Natori, T., Ohgomori, T., Muramoto, A., Shinjo, R., Matsuyama, Y., Ishiguro, N., & Kadomatsu, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-53 · Cited by 91
“For example, the CS-degrading enzyme chondroitinase ABC (CABC) enhances axonal regeneration/sprouting after CNS injury and consequently promotes functional recovery [8,9].”
BackgroundMothe, A. J., Tassew, N. G., Shabanzadeh, A. P., Penheiro, R., Vigouroux, R. J., Huang, L., Grinnell, C. M., Cui, Y., Fung, E., Monnier, P. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10987-7 · Cited by 94
Changes within maturing neurons limit axonal regeneration in the developing spinal cord
Blackmore, M. G., & Letourneau, P. C. (2006) · Journal of Neurobiology · doi:10.1002/neu.20224 · Cited by 98
“In the adult spinal cord, most current work seeks to enhance regeneration by neutralizing inhibitory signals (Bradbury et al., 2002; GrandPre et al., 2002; Fouad et al., 2004) and/or by grafting growth-permissive tissue into the site of injury (Jin et al.”
BackgroundBMP inhibition enhances axonal growth and functional recovery after spinal cord injury
Matsuura, I., Taniguchi, J., Hata, K., Saeki, N., & Yamashita, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05251.x · Cited by 91
“Intrathecal administration of chondroitinase ABC, an enzyme that removes glycosaminoglycan (GAG) chains from the protein core, following SCI promoted both the regeneration of various axon tracts as well as functional recovery (Bradbury et al. 2002).”
BackgroundGoussev, S., Hsu, J.-Y. C., Lin, Y., Tjoa, T., Maida, N., Werb, Z., & Noble-Haeusslein, L. J. (2003) · Journal of Neurosurgery: Spine · doi:10.3171/spi.2003.99.2.0188 · Cited by 87
Velardo, M. J., Bürger, C., Williams, P. R., Baker, H. V., López, M. C., Mareci, T. H., White, T. E., Muzyczka, N., & Reier, P. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3316-04.2004 · Cited by 91
“, 1999), extracellular matrix (ECM) changes (McKeon et al., 1999; Lemons et al., 2001; Bradbury et al., 2002; Tang et al., 2003), contusion fibrosis (Inman et al.”
BackgroundGaudet, A. D., Mandrekar-Colucci, S., Hall, J. C. E., Sweet, D. R., Schmitt, P. J., Xu, X., Guan, Z., Mo, X., Guerau-de-Arellano, M., & Popovich, P. G. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0735-16.2016 · Cited by 87
“Numerous neuron-extrinsic barriers also conspire to prevent efficient CNS growth and repair (McKeon et al., 1991; Bradbury et al., 2002; Brambilla et al., 2005; Donnelly and Popovich, 2008; Pineau et al., 2010; Alilain et al., 2011; Gaudet and Popovich, 2014).”
BackgroundRepair of spinal cord injuries: where are we, where are we going?
Fawcett, J. W. (2002) · Spinal Cord · doi:10.1038/sj.sc.3101328 · Cited by 91
Self-citationBiomaterial-based regenerative therapeutic strategies for spinal cord injury
Chen, K., Yu, W., Zheng, G., Zeng, X., Yang, C., Wang, Y., Yue, Z., Yuan, W., Hu, B., & Chen, H. (2024) · NPG Asia Materials · doi:10.1038/s41427-023-00526-4 · Cited by 109
“In 2002, a study demonstrated that ChABC could reduce glial scar formation to promote SCI recovery 158 .”
Overcoming neurite‐inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix
Cua, R. C., Lau, L. W., Keough, M. B., Midha, R., Apte, S. S., & Yong, V. W. (2013) · Glia · doi:10.1002/glia.22489 · Cited by 87
“972 VC 2013 Wiley Periodicals, Inc. chondroitin sulfate GAG chains using chondroitinase ABC (ChABC), a glycanase enzyme isolated from Proteus vulgaris bacteria, facilitates axonal regrowth and improves functional recovery (Bradbury and Carter, 2011; Bradbury et al., 2002).”
BackgroundInfluentialSiebert, J. R., Stelzner, D. J., & Osterhout, D. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.002 · Cited by 93
Miyashita, T., Koda, M., Kitajo, K., Yamazaki, M., Takahashi, K., Kikuchi, A., & Yamashita, T. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0776 · Cited by 90
“The intrathecal administration of chon-droitinase ABC—an enzyme that removes GAG chains from the protein core—following SCI promoted the regeneration of various axon tracts as well as functional recovery (Bradbury et al., 2002; Moon et al., 2001).”
The Lipid Sulfatide Is a Novel Myelin-Associated Inhibitor of CNS Axon Outgrowth
Winzeler, A. M., Mandemakers, W. J., Sun, M. Z., Stafford, M., Phillips, C. T., & Barres, B. A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3004-10.2011 · Cited by 89
“, 2009), the formation of the inhibitory glial scar (McKeon et al., 1991; Davies et al., 1997; Zuo et al., 1998; Fidler et al., 1999; Moon et al., 2001; Bradbury et al., 2002), and the presence of inhibitory myelin debris (McKerracher et al.”
BackgroundA Sweet Talk: The Molecular Systems of Perineuronal Nets in Controlling Neuronal Communication
van 't Spijker, H. M., & Kwok, J. C. F. (2017) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2017.00033 · Cited by 84
“Since the PNNs are involved in a variety of diseases, such as schizophrenia (Pantazopoulos et al., 2010), epilepsy (Arranz et al., 2014), Alzheimer’s disease (Brückner et al., 1999) and spinal cord injury (Bradbury et al., 2002), such an accessible tool for neuronal communication is very promising.”
BackgroundRecent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair
Li, J., Luo, W., Xiao, C., Zhao, J., Xiang, C., Liu, W., & Gu, R. (2023) · Theranostics · doi:10.7150/thno.84133 · Cited by 98
“Traditionally, chondroitin sulfate proteoglycans (CSPGs) have been the main component of glial scars and are thought to inhibit axon growth after SCI [136, 137].”
BackgroundChen, J., Bernreuther, C., Dihné, M., & Schachner, M. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.896 · Cited by 89
“Recognition molecules have the potential to favor such processes in a generally inhibitory environment by over-coming the inhibitory cues (Bradbury et al., 2002; Castellani et al., 2000; Mohajeri et al., 1996; Roonpra-punt et al., 2003; Silver and Miller, 2004; Webb et al., 2001; Yazaki et al.,…”
Bao, X., Mikami, T., Yamada, S., Faissner, A., Muramatsu, T., & Sugahara, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413423200 · Cited by 88
Spinal Interneuron Axons Spontaneously Regenerate after Spinal Cord Injury in the Adult Feline
Fenrich, K. K., & Rose, P. K. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0897-09.2009 · Cited by 89
“Also, cleaving the active regions of inhibitory molecules (Bradbury et al., 2002) or using antibodies to block their action (Schnell and Schwab, 1990; Bregman et al., 1995) promotes regeneration.”
BackgroundProteoglycans in brain development
Schwartz, N. B., & Domowicz, M. S. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000046278.34016.36 · Cited by 99
Recognition molecules and neural repair
Loers, G., & Schachner, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04409.x · Cited by 95
“Chondroitinase treatment of the injured spinal cord promotes recovery from spinal injuries (Bradbury et al. 2002) and it is noteworthy in this respect that inhibitory interneurons in the spinal cord also express abundant perineuronal nets containing the tenascins and CSPG.”
BackgroundGherardini, L., Gennaro, M., & Pizzorusso, T. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht217 · Cited by 87
“Thus, ChABC-facilitated plasticity could enhance functional recovery, either by enhanced sprouting of existing axons or by the formation of new connections at the injury site (Bradbury et al. 2002).”
BackgroundHasegawa, K., Chang, Y.-W., Li, H., Berlin, Y., Ikeda, O., Kane‐Goldsmith, N., & Grumet, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.024 · Cited by 93
“, 1997), and axonal regrowth is promoted by degrading CSPG with bacterial chondroitinase (Bradbury et al., 2002).”
BackgroundRolls, A., Cahalon, L., Bakalash, S., Avidan, H., Lider, O., & Schwartz, M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4540fje · Cited by 89
“Therefore, accelerating its degradation has been proposed as a potential treatment approach for CNS injuries (11, 12, 15).”
BackgroundRemyelination Therapy in Multiple Sclerosis
Harlow, D. E., Honce, J. M., & Miravalle, A. A. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00257 · Cited by 82
Guo, S., Wang, L., Xie, Y., Luo, X., Zhang, S., Xiong, L., Ai, H., Yuan, Z., & Wang, J. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.08.191 · Cited by 89
Zhang, L., Lei, Z., Guo, Z., Pei, Z., Chen, Y., Zhang, F., Cai, A., Mok, G., Lee, G., Swaminathan, V., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.594170 · Cited by 94
“Neutralization of the neuroinhibitory factors can facilitate axonal regeneration (Bradbury et al., 2002; Sivasankaran et al., 2004).”
BackgroundRecent insights on astrocyte mechanisms in CNS homeostasis, pathology, and repair
Hart, C. G., & Karimi‐Abdolrezaee, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24922 · Cited by 81
Biomaterials for spinal cord repair
Haggerty, A. E., & Oudega, M. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1362-7 · Cited by 93
A role for cAMP in regeneration of the adult mammalian CNS
Spencer, T., & Filbin, M. T. (2003) · Journal of Anatomy · doi:10.1111/j.1469-7580.2004.00259.x · Cited by 88
“The glial scar, which forms a physical regenerative barrier, also contains molecules, such as chondroitin sulphate proteoglycans (CSPGs), which act as inhibitors of regeneration (McKeon et al. 1991; Niederost et al. 1999; Bradbury et al. 2002).”
BackgroundVerdú, E., García‐Alías, G., Forés, J., López‐Vales, R., & Navarro, X. (2003) · Glia · doi:10.1002/glia.10217 · Cited by 98
“In fact, chondroitinase-ABC treatment, which degrades CSPGs, allows neurite elongation (Zuo et al., 1998) and promotes axonal regeneration after spinal cord injury (Yick et al., 2000; Bradbury et al., 2002).”
The brain tissue response to surgical injury and its possible contribution to glioma recurrence
Hamard, L., Ratel, D., Selek, L., Berger, F. R., van der Sanden, B. P. J., & Wion, D. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2096-y · Cited by 89
The Role of Biomaterials in Peripheral Nerve and Spinal Cord Injury: A Review
Kaplan, B., & Levenberg, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031244 · Cited by 92
Alia, C., Spalletti, C., Lai, S., Panarese, A., Micera, S., & Caleo, M. (2016) · Scientific Reports · doi:10.1038/srep37823 · Cited by 94
Rhodes, K. E., Moon, L. D. F., & Fawcett, J. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00285-9 · Cited by 87
“, 2003), and both in vitro and in vivo experiments have demonstrated inhibitory effects of CSPGs on axonal growth (e.g. Snow et al., 1990; McKeon et al., 1991, 1995; Dou and Levine, 1994; Smith-Thomas et al., 1994, 1995; Fidler et al., 1999; Niederöst et al., 1999; Moon et al., 2001; Bradbury et al., 2002; Chen et al.…”
Self-citationDifferences in neuroplasticity after spinal cord injury in varying animal models and humans
Hanna, A. S., Filipp, M. E., Travis, B. J., Henry, S. S., Idzikowski, E., Magnuson, S. A., Loh, M., & Hellenbrand, D. J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.243694 · Cited by 94
“Without similar interventions, long-distance reorganization is minimal (Bradbury et al., 2002; Kim et al., 2004; Cafferty et al., 2010; Liu et al., 2010).”
Spinal cord regeneration: where fish, frogs and salamanders lead the way, can we follow?
Quiroz, J. F. D., & Echeverri, K. (2013) · Biochemical Journal · doi:10.1042/bj20121807 · Cited by 96
The Extracellular Matrix Glycoprotein Tenascin-C Is Beneficial for Spinal Cord Regeneration
Chen, J., Lee, H. J., Jakovčevski, I., Shah, R., Bhagat, N., Loers, G., Liu, H., Meiners, S. A., Taschenberger, G., Kügler, S., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.133 · Cited by 93
“0 Intact TNC+/+ (7) (7) TNC−/− (9) (9) (6) (9) (6) (7) (4) (5)”
Rodent, large animal and non-human primate models of spinal cord injury
Nardone, R., Florea, C., Höller, Y., Brigo, F., Versace, V., Lochner, P., Golaszewski, S. M., & Trinka, E. (2017) · Zoology · doi:10.1016/j.zool.2017.06.004 · Cited by 86
Molecular Cloning and Characterization of Chondroitin-4-O-sulfotransferase-3
Kang, H.-G., Evers, M. R., Xia, G., Baenziger, J. U., & Schachner, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204907200 · Cited by 84
Duncan, B. W., Murphy, K. E., & Maness, P. F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.625340 · Cited by 93
Dyck, S. M., Alizadeh, A., Santhosh, K. T., Proulx, E. H., Wu, C., & Karimi‐Abdolrezaee, S. (2015) · Stem Cells · doi:10.1002/stem.1979 · Cited by 94
Reiner, A. J., Heldt, S. A., Presley, C. S., Guley, N., Elberger, A. J., Deng, Y., D’Surney, L., Rogers, J. T., Ferrell, J. M., Bu, W., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010758 · Cited by 86
Bukhari‐Parlakturk, N., Torres, L., Robinson, J. K., & Tsirka, S. E. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3339-11.2011 · Cited by 85
“The tPA/plasmin system contributes to ChABC-mediated neurite outgrowth ChABC cleavage of the GAG chains on CSPGs is known to enhance axon growth after SCI (Moon et al., 2001; Bradbury et al., 2002).”
BackgroundResultInfluentialBioengineered Scaffolds for Spinal Cord Repair
Wang, M., Zhai, P. C., Chen, D., Schreyer, D. J., Sun, X., & Cui, F. (2011) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2010.0648 · Cited by 102
“42,51 63”
Enzymatic Synthesis of Homogeneous Chondroitin Sulfate Oligosaccharides
Li, J., Su, G., & Liu, J. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201705638 · Cited by 88
Rapid and robust restoration of breathing long after spinal cord injury
Warren, P. M., Steiger, S. C., Dick, T. E., MacFarlane, P. M., Alilain, W. J., & Silver, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06937-0 · Cited by 85
Fan, J., Xiao, Z., Zhang, H., Chen, B., Tang, G.-Q., Hou, X., Ding, W., Wang, B., Zhang, P., Dai, J., et al. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1281 · Cited by 89
“…2003; Taylor et al., 2006; Trivedi et al., 2006), using growth-promoting agents (Pearse, 2004), disrupting glial scar and myelin formation (Bradbury et al., 2002; Brosamle et al., 2000; Fawcett and Asher, 1999; Li and Strittmatter, 2003; Merkler et al., 2001; Silver and Miller, 2004),…”
Fabes, J., Anderson, P., Yáñez‐Muñoz, R. J., Thrasher, A., Brennan, C., & Bolsover, S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04704.x · Cited by 83
“In contrast, neighbouring rubrospinal axons, which do not express EphA4, retract less and can advance some way towards the lesion before they are stopped by another inhibitory factor or factors, among which are chondroitin sulphate proteoglycans (Fitch & Silver, 1997; Bradbury et al., 2002; Tang et al., 2003).”
BackgroundGiger, R. J., Venkatesh, K., Chivatakarn, O., Raiker, S. J., Robak, L. A., Höfer, T., Lee, H., & Rader, C. M. (2008) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2008-00440 · Cited by 91
“Furthermore, chondroitin sulfate proteoglycans (CSPGs) which are expressed throughout the brain and spinal cord, inhibit neuronal growth and are upregulated following traumatic CNS injury, particularly near the site of astroglial scar formation (McKeon et al., 1995; Davies et al., 1999; Bradbury et al., 2002).”
Bioengineering Neural Stem/Progenitor Cell-Coated Tubes for Spinal Cord Injury Repair
Zahir, T., Nomura, H., Guo, X. D., Kim, H. S., Tator, C. H., Morshead, C. M., & Shoichet, M. S. (2008) · Cell Transplantation · doi:10.3727/096368908784153887 · Cited by 84
Ishii, M., & Maeda, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806331200 · Cited by 84
Wang, Y., Moges, H., Bharucha, Y., & Symes, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.006 · Cited by 84
Role of IL-6 in spinal cord injury in a mouse model
Nakamura, M., Okada, S., Toyama, Y., & Okano, H. (2005) · Clinical reviews in allergy and immunology · doi:10.1385/criai:28:3:197 · Cited by 81
Suzuki, T., Akimoto, M., Imai, H., Ueda, Y., Mandai, M., Yoshimura, N., Swaroop, A., & Takahashi, M. (2007) · Cell Transplantation · doi:10.3727/000000007783464966 · Cited by 83
Papastefanaki, F., Jakovčevski, I., Poulia, N., Djogo, N., Schulz, F., Martinović, T., Ćirić, D., Loers, G., Voßmeyer, T., Weller, H., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.50 · Cited by 82
Yip, P. K., Wong, L.-F., Pattinson, D., Battaglia, A., Grist, J., Bradbury, E. J., Maden, M., McMahon, S. B., & Mazarakis, N. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl251 · Cited by 85
“Bradbury, E.J., Moon, L.D., Popat, R.J., King, V.R., Bennett, G.S., Patel, P.N., Fawcett, J.W. and McMahon, S.B. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury.”
BackgroundMethodSelf-citationDobbertin, A., Rhodes, K. E., Garwood, J., Properzi, F., Heck, N., ROGERS, J. H., Fawcett, J. W., & Faissner, A. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00257-4 · Cited by 101
Self-citationNeuroinflammatory responses of microglia in central nervous system trauma
Shields, D. C., Haque, A., & Banik, N. L. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20965786 · Cited by 88
“This secondary injury component includes deposition of chondroitin-sulfate proteoglycan (extracellular matrix protein) by reactive astrocytes that inhibits axonal regeneration.(26) Microglial and astrocytic processes contribute to a mesh-like (fibrous/glial) structure that includes infiltrating immune cells such as fi…”
BackgroundRaspa, A., Carminati, L., Pugliese, R., Fontana, F., & Gelain, F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.027 · Cited by 85
Targeting the Nogo Receptor to Treat Central Nervous System Injuries
Lee, D. H. S., Strittmatter, S. M., & Sah, D. W. Y. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1228 · Cited by 82
Functions of Chondroitin Sulfate/Dermatan Sulfate Chains in Brain Development
Purushothaman, A., Fukuda, J., Mizumoto, S., ten Dam, G. B., van Kuppevelt, T. H., Kitagawa, H., Mikami, T., & Sugahara, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700630200 · Cited by 79
Starkey, M. L., Davies, M., Yip, P. K., Carter, L. M., Wong, D. J. N., McMahon, S. B., & Bradbury, E. J. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21944 · Cited by 91
“…observed in virtually all DRG neurons following peripheral nerve injury (Verge et al., 1990; Chong et al., 1992; Schreyer and Skene, 1993), and largely unchanged levels of GAP-43 following dorsal root (Schreyer and Skene, 1993; Chong et al., 1994) or dorsal column (Bradbury et al., 2002) injury.”
BackgroundMethodResultInfluentialSelf-citationSchweitzer, J., Becker, T., Becker, C. G., & Schachner, M. (2003) · Glia · doi:10.1002/glia.10192 · Cited by 82
Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates
Lindsay, S. L., McCanney, G. A., Willison, A., & Barnett, S. C. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0311-0 · Cited by 84
Hayes, A. J., & Melrose, J. (2020) · Biomolecules · doi:10.3390/biom10091244 · Cited by 89
Susarla, B. T. S., Laing, E. D., Yu, P., Katagiri, Y., Geller, H. M., & Symes, A. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07470.x · Cited by 89
Differential responses of spinal axons to transection: influence of the NG2 proteoglycan
de Castro, R., Tajrishi, R., Claros, J., & Stallcup, W. B. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.027 · Cited by 80
Jefferson, S. C., Tester, N. J., & Howland, D. R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4459-10.2011 · Cited by 80
“The volume is greater than that used in rodent studies (Bradbury et al., 2002) due to the larger size of the cat spinal cord.”
BackgroundBareyre, F., & Loy, K. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.245951 · Cited by 87
“However it can be achieved to a limited extent with genetic modifications, pharmaceutical interventions or extracellular matrix degeneration, but even though functional benefits remain small (Bradbury et al., 2002; Liu et al., 2010; Ruschel et al., 2015).”
Gu, W.-L., Fu, S.-L., Wang, Y.-X., Li, Y., Lü, H.-Z., Xu, X.-M., & Lu, P.-H. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-128 · Cited by 80
“It has been well known that CSPGs are one of the inhibitory molecules found in glial scars and inhibit neurite outgrowth and induce growth cone collapse after spinal cord injury (SCI) [26,27] and Chase ABC application could promote axonal regeneration by digesting CSPGs in vitro [48] and in vivo [22,28,49,50].”
BackgroundMeijs, M. F. L., Timmers, L., Pearse, D. D., Tresco, P. A., Bates, M. L., Joosten, E. A. J., Bunge, M. B., & Oudega, M. (2004) · Journal of Neurotrauma · doi:10.1089/neu.2004.21.1415 · Cited by 80
“CSPG is a member of a family of extracellular matrix molecules that obstruct axonal regeneration after injury (Bradbury et al., 2002; Moon et al., 2001; Morgenstern et al., 2002; Yamaguchi, 2000) and contribute to glial scar-ring at CNS injury sites (Fitch and Silver, 1997; Haas et al., 1999; Jones…”
Rolls, A., Avidan, H., Cahalon, L., Schori, H., Bakalash, S., Litvak, V., Lev, S., Lider, O., & Schwartz, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03676.x · Cited by 79
“Enzymatic degradation of CSPG leads to axonal regeneration in vivo and neurite outgrowth in vitro (Yick et al., 2000; Bradbury et al., 2002; Zuo et al., 2002; Tropea et al., 2003; Chau et al., 2004).”
BackgroundHitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury
Giza, C. C., Kolb, B., Harris, N. G., Asarnow, R. F., & Prins, M. L. (2009) · Developmental Neurorehabilitation · doi:10.3109/17518420903087558 · Cited by 76
“Cleavage of chondroitin sulphate side-chains results in a recapitulation of normally developmentally-restricted axonal sprouting in spinal cord [112] as well as dendritic sprouting after neutralization of the growth-inhibitory molecule NOGO-a [113].”
BackgroundPakulska, M. M., Tator, C. H., & Shoichet, M. S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.016 · Cited by 80
Alizadeh, A., Dyck, S. M., Kataria, H., Shahriary, G. M., Nguyen, D. H., Santhosh, K. T., & Karimi‐Abdolrezaee, S. (2017) · Glia · doi:10.1002/glia.23150 · Cited by 86
“We show for the first time a remarkable capacity for Nrg-1 to attenuate the upregulation of CSPGs in activated astrocytes in vitro and in SCI. CSPGs play multifaceted inhibitory roles in neural regeneration (Bradbury et al., 2002; Dyck and Karimi-Abdolrezaee, 2015).”
BackgroundA perspective on the role of class III semaphorin signaling in central nervous system trauma
Mecollari, V., Nieuwenhuis, B., & Verhaagen, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00328 · Cited by 79
“This is particularly interesting since both approaches have been reported to be beneficial for functional recovery after CNS injury (Bradbury et al., 2002; Davies et al., 2004; Soleman et al., 2012 and reviewed in Kwok et al., 2011).”
Background
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.